Jan 11 (Reuters) - Knight Therapeutics Inc GUD.TO :
* KNIGHT THERAPEUTICS INC - ENTERED INTO LICENSE AGREEMENT WITH PUMA BIOTECHNOLOGY GRANTING CO EXCLUSIVE RIGHT TO COMMERCIALIZE NERLYNX IN CANADA
Jan 11 (Reuters) - Knight Therapeutics Inc GUD.TO :
* KNIGHT THERAPEUTICS INC - ENTERED INTO LICENSE AGREEMENT WITH PUMA BIOTECHNOLOGY GRANTING CO EXCLUSIVE RIGHT TO COMMERCIALIZE NERLYNX IN CANADA